StudyMD 0.3.2 - Persistent Cross-Site Scripting
13Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 5.1epss 0.5%
exploitation probability
0.5%top 62% of all CVEs
observed exploitation
nono source reports it
StudyMD 0.3.2 contains a persistent cross-site scripting vulnerability that allows attackers to inject malicious scripts into markdown files. Attackers can upload crafted markdown files with embedded JavaScript payloads that execute when the file is opened, potentially enabling remote code execution.
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N
Affected products
jotron · StudyMD